US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

126.63

+15.6814.13%

Pre-market: 124.92-1.7100-1.35%05:30 EDT

Volume:3.49M

Turnover:442.93M

Market Cap:5.29B

PE:-19.65

High:136.72

Open:111.60

Low:110.56

Close:110.95

52wk High:136.72

52wk Low:32.00

Shares:41.78M

Float Shares:32.29M

Volume Ratio:5.48

T/O Rate:10.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.4439

EPS(LYR):-111.9114

ROE:-72.06%

ROA:-43.45%

PB:6.50

PE(LYR):-1.13

Loading ...

Overview Company News Filings

Buy Rating Reiterated as Strong VDPHL01 Data De-Risk Program and Drive Price Target Increase to $120

Top Midday Gainers

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton

BUZZ-Absci rises as brokerage highlights growing opportunity in hair‑loss market

Veradermics Reports Positive Phase 2/3 Data for VDPHL01

BUZZ-Veradermics jumps after experimental oral hair loss pill posts positive late‑stage trial results

Veradermics Shares Gain on Positive Data from Hair Loss Treatment Study

A new version of an old drug is helping men grow back some of their hair

Veradermics Inc - Vdphl01 Shows Favorable Safety Profile With Adverse Event Rates Similar to Placebo

THOMSON REUTERS

Veradermics Inc - Vdphl01 Meets All Primary and Key Secondary Endpoints With High Statistical Significance

THOMSON REUTERS

Veradermics’ Oral Vdphl01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss

THOMSON REUTERS

Veradermics to report Phase 2/3 VDPHL01 trial topline results in male hair loss

Veradermics to Hold Conference Call to Discuss Topline Results From Phase 2/3 ‘302’ Study of Vdphl01 in Males With Mild-to-Moderate Pattern Hair Loss

THOMSON REUTERS

Veradermics Is Maintained at Outperform by Leerink Partners

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/MANE/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":126.63,"timestamp":1791489600000,"preClose":110.95,"halted":0,"volume":3490511,"hourTrading":{"tag":"盘前","latestPrice":124.92,"preClose":126.63,"latestTime":"05:30 EDT","volume":27,"amount":3372.53004,"timestamp":1791538240963,"change":-1.71,"changeRate":-0.013504,"amplitude":0.000474},"delay":0,"changeRate":0.14132492113564663,"floatShares":32290700,"shares":41778687,"eps":-6.443948,"marketStatus":"Pre-Mkt","change":15.68,"latestTime":"10-09 06:54:55 EDT","open":111.6,"high":136.715,"low":110.56,"amount":442931046.13335997,"amplitude":0.235737,"askPrice":142.2,"askSize":100,"bidPrice":126.06,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-6.443948,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":126.63,"preHourTrading":{"tag":"盘前","latestPrice":124.92,"preClose":126.63,"latestTime":"05:30 EDT","volume":27,"amount":3372.53004,"timestamp":1791538240963,"change":-1.71,"changeRate":-0.013504,"amplitude":0.000474},"postHourTrading":{"tag":"盘后","latestPrice":126,"preClose":126.63,"latestTime":"19:56 EDT","volume":6110,"amount":773199.2667,"timestamp":1791503816611,"change":-0.63,"changeRate":-0.004975,"amplitude":0.00598},"volumeRatio":5.47667904053933,"impliedVol":1.2597,"impliedVolPercentile":1},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":32290700,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":5.47667904053933,"shares":41778687,"dividePrice":0,"high":136.715,"amplitude":0.235737,"preClose":110.95,"low":110.56,"week52Low":32,"pbRate":"6.50","week52High":136.715,"institutionHeld":0,"latestPrice":126.63,"committee":-0.923077,"eps":-6.443948,"divideRate":0,"volume":3490511,"delay":0,"ttmEps":-6.443948,"open":111.6,"prevYearClose":17,"prevWeekClose":116.76,"prevMonthClose":121.23,"prevQuarterClose":121.23,"fiveDayClose":117.22,"twentyDayClose":98.14,"sixtyDayClose":123.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MANE","fiscalQuarterEnding":"2026/06","expectedEps":-0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-10-07","current":-19.650997,"percent":0.431953,"low":-67.545361,"twenty":-53.643529,"median":-47.365301,"eighty":-35.571997,"high":-9.296992,"avg":-45.829099,"sd":10.305782,"marketCap":4552363618},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-17","current":-39.540857,"twenty":-39.536494,"median":-33.608872,"eighty":-30.279902,"marketCap":2767662294},{"date":"2026-04-24","current":-36.942854,"twenty":-39.536494,"median":-33.738647,"eighty":-30.421684,"marketCap":2585815082},{"date":"2026-05-01","current":-52.813611,"twenty":-40.831905,"median":-34.49692,"eighty":-30.615983,"marketCap":3696688710},{"date":"2026-05-08","current":-63.45616,"twenty":-42.963163,"median":-35.411007,"eighty":-30.844978,"marketCap":4441613943},{"date":"2026-05-15","current":-51.496667,"twenty":-46.59847,"median":-35.988193,"eighty":-30.890717,"marketCap":4368307751},{"date":"2026-05-22","current":-50.831536,"twenty":-50.412067,"median":-36.702792,"eighty":-31.015444,"marketCap":4311886693},{"date":"2026-05-29","current":-50.670085,"twenty":-50.670085,"median":-37.508333,"eighty":-31.226637,"marketCap":4298191318},{"date":"2026-06-05","current":-49.857433,"twenty":-50.482929,"median":-39.295461,"eighty":-31.282151,"marketCap":4229256485},{"date":"2026-06-12","current":-46.493546,"twenty":-50.049515,"median":-39.519044,"eighty":-31.356106,"marketCap":3943908052},{"date":"2026-06-18","current":-45.24748,"twenty":-50.006173,"median":-40.004977,"eighty":-31.7244,"marketCap":3838207974},{"date":"2026-06-26","current":-58.79168,"twenty":-50.634624,"median":-40.906894,"eighty":-31.961359,"marketCap":4987121867},{"date":"2026-07-02","current":-63.278505,"twenty":-51.067836,"median":-42.661209,"eighty":-32.20951,"marketCap":5367725705},{"date":"2026-07-10","current":-61.520221,"twenty":-53.048338,"median":-44.057315,"eighty":-32.416525,"marketCap":5218575793},{"date":"2026-07-17","current":-52.123009,"twenty":-54.2625,"median":-44.976596,"eighty":-32.698555,"marketCap":4421438445},{"date":"2026-07-24","current":-57.062948,"twenty":-54.490042,"median":-45.472923,"eighty":-32.869852,"marketCap":4840478675},{"date":"2026-07-31","current":-51.531989,"twenty":-54.856474,"median":-45.794173,"eighty":-33.139095,"marketCap":4371304020},{"date":"2026-08-07","current":-53.511905,"twenty":-54.832834,"median":-46.684099,"eighty":-33.593192,"marketCap":4539254342},{"date":"2026-08-14","current":-50.036631,"twenty":-54.832834,"median":-47.316049,"eighty":-33.69117,"marketCap":4637595096},{"date":"2026-08-21","current":-47.476198,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"marketCap":4400283923},{"date":"2026-08-28","current":-45.893958,"twenty":-54.263485,"median":-47.316049,"eighty":-33.861631,"marketCap":4253635646},{"date":"2026-09-04","current":-44.06379,"twenty":-54.197488,"median":-46.684099,"eighty":-34.12449,"marketCap":4084008294},{"date":"2026-09-11","current":-44.239594,"twenty":-54.067463,"median":-46.421397,"eighty":-34.344005,"marketCap":4100302547},{"date":"2026-09-18","current":-48.99082,"twenty":-53.916605,"median":-46.349247,"eighty":-34.830885,"marketCap":4540665180},{"date":"2026-09-25","current":-52.164315,"twenty":-53.806823,"median":-46.818058,"eighty":-35.200053,"marketCap":4834797337},{"date":"2026-10-02","current":-52.840485,"twenty":-53.806823,"median":-47.237246,"eighty":-35.451255,"marketCap":4897467541},{"date":"2026-10-07","current":-49.117039,"twenty":-53.643529,"median":-47.365301,"eighty":-35.571997,"marketCap":4552363618}],"updateTime":1791518812832},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630146323","title":"Buy Rating Reiterated as Strong VDPHL01 Data De-Risk Program and Drive Price Target Increase to $120","url":"https://stock-news.laohu8.com/highlight/detail?id=2630146323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630146323?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:45","pubTimestamp":1777315522,"startTime":"0","endTime":"0","summary":"Geoff Meacham, an analyst from Citi, maintained the Buy rating on Veradermics, Incorporated. The associated price target was raised to $120.00. Geo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-vdphl01-data-de-risk-program-and-drive-price-target-increase-to-120-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-vdphl01-data-de-risk-program-and-drive-price-target-increase-to-120-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630113053","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2630113053","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630113053?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:01","pubTimestamp":1777312877,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) said Monday it has priced an underwritten offering of about 29.2 million shares at $6.00 each to raise about $175 million to help fund its clinical trial.Shares soared 43% a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORKA","MANE","BK4007","BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630231132","title":"BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton","url":"https://stock-news.laohu8.com/highlight/detail?id=2630231132","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630231132?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:00","pubTimestamp":1777312821,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL6N41A0MJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336760.USD","IE0034235303.USD","IE0002270589.USD","IE0004445015.USD","IE00BJJMRX11.SGD","LU2023250504.SGD","LU2023251221.USD","LU1699723380.USD","LU0787776722.HKD","LU1035773651.USD","SG9999014567.USD","LLII","MSFO","LU1935042991.SGD","LU1236620750.USD","LU1303367103.USD","SGXZ51526630.SGD","LU1989764664.SGD","SG9999015341.SGD","BK4608","SGXZ99366536.SGD","IE00BSNM7G36.USD","LU0323591593.USD","LU0072461881.USD","LU2506952170.USD","SNXX","IE00B19Z3581.USD","LU2491050071.SGD","BK4528","IE00B3S45H60.SGD","LU2148611432.USD","LU2458330243.SGD","LU1564329032.USD","LU1069344957.HKD","LU0985481810.HKD","LU2279689827.SGD","LU0056508442.USD","LU0174119429.USD","LU1951200564.SGD","IE00BN0W2T93.GBP","LU1983299246.USD","LU0211331839.USD","LU0096364046.USD","LU0879622024.SGD","LU2237438978.USD","IE0004091025.USD","LU2357305700.SGD","IE00BMPRXR70.SGD","SG9999014542.SGD","LU0823414478.USD","LU0077335932.USD","LU0154236417.USD","LU2361044865.SGD","BK4114","LU2100268510.USD","BK4545","LU2168564065.EUR","BK4592","BK4566","LU1169590202.USD","LU2420271590.USD","LU1093756168.USD","IE00BJJMRY28.SGD","LU1093756325.SGD","LU2237443978.SGD","MUU","LU0149725797.USD","IE00B5949003.HKD","LU2272731782.SGD","LU2362541273.HKD","LU2463028550.USD","BK4008","LU2244417387.USD","IE00B1BXHZ80.USD","LU2237957902.USD","LU0385154629.USD","LU2487616109.SGD","LU0081259029.USD","LU2106854487.HKD","LU1064131342.USD","LU0082616367.USD","LU1340139317.AUD","LU0310799852.SGD","LU2047632596.USD","LU2317271919.USD","LU0289941410.SGD","LU2191332357.HKD","LU2491049909.HKD","LU1778281490.HKD","IE00BBT3K403.USD","ELIL","SG9999015978.USD","BK4116","HK0000819398.USD","LU1267930730.SGD","LU1983260115.SGD","SG9999014575.USD","LU1815333072.USD","LU2324357040.USD","LU1291159041.SGD","LU1316542783.SGD","LU1989763005.USD","LU2087625088.SGD","IE00BVYPNP33.GBP","LU1430594728.SGD","LU2430703178.SGD","LU0210528500.USD","LU2065171311.SGD","LU0256863811.USD","BK4115","LU0321505439.SGD","LU0708995401.HKD","LU1670711123.USD","LU0882574139.USD","LU0310800379.SGD","LU1923622614.USD","MULL","TERG","LU0097036916.USD","LU0965508806.USD","LU2097829019.USD","LU2433249047.HKD","BK4168","LU0094547139.USD","LU1066051498.USD","LU0203345920.USD","LU0820561909.HKD","LU1301847155.USD","LU0061475181.USD","LU2092937148.SGD","SG9999004303.SGD","SG9999018857.SGD","SG9999002232.USD","LU1582986359.USD","LU1674673691.USD","LU0266013472.USD","LU2125909247.SGD","LU1066053197.SGD","LU2089985449.USD","LU2471134952.CNY","LU0208291251.USD","LU1670710588.SGD","LU2290526834.HKD","LU2237443622.USD","BK4141","LU2065171402.SGD","LU1074936037.SGD","LU2552382058.USD","LU0889565916.HKD","LU1244550221.USD","IE00BFXG1179.USD","LU0528227936.USD","LU2360108059.USD","LU0792757196.USD","IE00BMPRXQ63.HKD","IE00BKPKM429.USD","LU1670756490.USD","LU0823417737.USD","LU2168564222.USD","LU2404859667.USD","IE00BLSP4239.USD","LU0353189763.USD","LU1267930573.SGD","LU1188199696.SGD","LU1621768115.EUR","LU0784384876.USD","LU2404859741.USD","ADBG","DPZ","LU1861558580.USD","BK4007","LU0444971666.USD","BK0028","LU0511384066.AUD","IE00BN8TJ469.HKD","LU2210149790.SGD","LU0289739699.SGD","IE00BJTD4V19.USD","LU1670628061.USD","BK4134","LU0426412945.USD","IE0003U64NQ7.SGD","LU0138981039.USD","LU0061474960.USD","IE00BWXC8680.SGD","LU0029864427.USD","BK4190","LU0964807845.USD","IE00BJJMRZ35.SGD","LU0210533765.USD","LU0210536198.USD","SGXZ31699556.SGD","LU1814569148.SGD","SG9999001176.USD","LU0724617625.USD","LU1803068623.USD","IE00B4YYXB79.USD","LU2360106780.USD","LU1582986433.USD","HK0000532082.HKD","LU1934455277.USD","LU2237443382.USD","LU0894485498.HKD","IE0034390439.USD","LU2473716301.USD","LU1823568750.SGD","IE00B3SWFQ91.USD","LU2237443549.SGD","IE00BKDWB100.SGD","LU2860962120.EUR","BK7095","LU0960925559.SGD","LU2125154778.USD","LU1236620834.HKD","LU0757359954.USD","LU2236285917.USD","LU2092627202.USD","LU1989771016.USD","ALBG","LU2505996509.AUD","LU2265009873.SGD","LU0823421333.USD","IE00B19Z8X17.USD","LU2720916845.USD","LU0289960550.SGD","BK4527","LU0708994859.HKD","BK4588","IE00BFXG0V08.USD","LU0823434740.USD","LLYZ","LU0965509010.AUD","BK4170","LU0689626769.HKD","LU0162691827.USD","BK4189","LU0314106906.USD","LU1668664300.SGD","LU1267930490.SGD","LU1720051017.SGD","LU2506951792.HKD","LU1366192091.USD","LU0859254822.USD","IE0009356076.USD","LU0098860793.USD","SG9999013999.USD","LU2089284900.SGD","LU0080751232.USD","LU2413666699.HKD","LU0823434583.USD","LU1162221912.USD","LU0058720904.USD","LU1119994496.HKD","BK4561","IE00B19Z8W00.USD","LU0426417589.USD","BK4504","LU1621767810.EUR","LU2023250843.SGD","BK4553","LU1400636657.SGD","IE000M9KFDE8.USD","LU1037948541.HKD","IE00B5TLWC47.USD","SG9999015986.USD","BK4581","LU1861220033.SGD","LU1621767737.EUR","LU0265550359.USD","BK0046","LU2322448957.HKD","LU0788109477.HKD","LU0069063385.USD","LU1429558221.USD","GB00B4QBRK32.GBP","LU0203201768.USD","LU0353189680.USD","LU1691799644.USD","LU0976567544.SGD","IE0009355771.USD","LU1032955483.USD","BK4551","LU0882574055.USD","IE00BQXX3F31.USD","LU0476273544.USD","LU1043141396.HKD","LU1582987597.SGD","LU2063271972.USD","LU0170899867.USD","IE00BK4W5M84.HKD","IE00B775SV38.USD","LU2471134523.USD","IE00BDRTCR15.USD","LU1244550494.USD","LU1732799900.SGD","LU0347712357.USD","LU2242650005.HKD","BK4559","SG9999014906.USD","HK0000914660.USD","BK4532","LU0689472784.USD","LU0823414551.USD","IE000W1ABFV2.USD","QCML","LU0070217475.USD","SPOG","LU1127390331.HKD","LU2168564149.EUR","LU0225284248.USD","LU2112291526.USD","LU0006306889.USD","LU1914381329.SGD","LU1121112475.USD","LU0784385840.USD","LU1280957306.USD","LU0444973449.USD","LU1221951129.SGD","LU1878469433.USD","LU1894683264.USD","IE0009G5SDU7.USD","IE00B2B36J28.USD","LU0994945656.USD","GB00BDT5M118.USD","LU0690374615.EUR","LU2746668974.SGD","BK7504","BK0239","LU1046421795.USD","LU0348723411.USD","LU1202635105.USD","LU2097344431.USD","LU0306807586.USD","MSFY","IE00BMPRXN33.USD","SG9999015945.SGD","LU1564329115.USD","LU2764262908.HKD","LU1323610961.USD","LU2275660780.HKD","LU1564329628.SGD","LU1935043536.SGD","MSFW","LU0070302665.USD","LU2028103732.USD","LU0957808578.USD","BK4139","IE00BKVL7J92.USD","IE0034235188.USD","LU2347655073.USD","LU0072462426.USD","LU1861214812.USD","JPMO","LU2468319806.SGD","BK4571","LU2413666426.HKD","LU1674673428.USD","BK4573","IE00BK4W5L77.USD","LU1244550577.SGD","LU1951198990.SGD","LU1861215975.USD","LU0187121727.USD","IE0005OL40V9.USD","MSFL","LU0308772762.SGD","LU0312595415.SGD","LU0472753341.HKD","LU2543165471.USD","LU0203202063.USD","LU1670711040.USD","LU1670627923.USD","IE000KEQY171.SGD","LU1334329650.SGD","LU0868494708.USD","LU2505996681.GBP","LU0471298694.HKD","LU0057025933.USD","BK4598","LU2247934214.USD","LU1935042488.USD","LU0557290698.USD","LU0757359368.USD","LU0949170426.SGD","IE00BYQQ9H92.USD","LU0211328371.USD","LU0320765059.SGD","BK4023","LU1718418525.SGD","SG9999014880.SGD","LU0661504455.SGD","LU2360107168.USD","MUD","LU0011850046.USD","LU0861579265.USD","CRMX","BK4525","IE0002141913.USD","LU1116320737.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","LU1181866309.USD","LU0289961442.SGD","LU0053666078.USD","LU0868494617.USD","LU2089984988.USD","LU2452424414.USD","LU1934455863.HKD","LU0006061336.USD","LU2360032135.SGD","LU1935042215.USD","LU1868836591.USD","LU0320765646.SGD","BK4155","PTON","LU1116320901.HKD","LU2362541513.USD","LU0251132253.USD","BK4604","LU2095319765.USD","LU2272731600.USD","SG9999018865.SGD","JPO","SG9999017495.SGD","BK4585","BK4021","BK4579","IE00BQXX3D17.EUR","IE00B19Z3B42.SGD","LU2271345857.HKD","ELIS","IE00BFSS7M15.SGD","SG9999000418.SGD","LU0672654240.SGD","LU1037948897.HKD","BK4575","LU0496365809.HKD","LU1228905037.USD","LU0124676726.USD","IE00B4R5TH58.HKD","LU0949170772.SGD","LU1551013425.SGD","LU3102509885.SGD","LU2456880835.USD","LU1633808545.USD","LU1582987324.SGD","LU0211327993.USD","BK4516","QCMD","IE00BJT1NW94.SGD","LU0950375773.USD","IE00B19Z6F94.USD","LU1506573853.SGD","LU0738911758.USD","LU0114720955.EUR","BK4612","IE0004086264.USD","LU1923623000.USD","LU2048586759.USD","LU1267930813.SGD","IE00BN0W2V16.EUR","LU1435385759.SGD","LU1629891620.HKD","LU1974910355.USD","IE00BFTCPJ56.SGD","BK4113","LU0323239441.USD","LU2506952097.USD","LU1989773731.SGD","LU0889565833.HKD","LU0061474705.USD","LU0553294199.USD","LU2168564495.EUR","LU1989764748.USD","LU1868836757.USD","LU0726765562.USD","LU0238689110.USD","LU0320765489.SGD","LU0784385170.HKD","LU0345769631.USD","SG9999014898.SGD","IE00BN29S564.USD","LU0823417653.USD","BK4554","LU0456855351.SGD","LU1839511570.USD","LU0354030438.USD","LU0175139822.USD","LU2242649171.HKD","LU2384288077.EUR","LU2750360997.AUD","LU0096362180.USD","LU1057294990.SGD","LU2756315664.SGD","BK4605","BK4143","LU0390134368.USD","LU0107464264.USD","LU1003077747.HKD","LU2092937221.SGD","LU2361044949.HKD","LU0211326755.USD","LU2506951875.HKD","LU0198837287.USD","LU0203347892.USD","LU2249611893.SGD","LU2592432038.USD","LU0795875169.SGD","LU0079474960.USD","IE00B19Z9505.USD","LU1023059063.AUD","SG9999001176.SGD","MVLL","LU2471134796.USD","BK4587","LU2098885051.SGD","LU2347655156.SGD","SG9999015358.SGD","BK4538","IE00BJTD4N35.SGD","IE00B7KXQ091.USD","LU0345770308.USD","LU0642271901.SGD","LU0784383803.USD","LU1989772840.SGD","SGXZ57979304.SGD","BK4515","LU0225283273.USD","LU0471298777.SGD","LU2506951958.HKD","LU2491050154.USD","SG9999001077.SGD","LU0985320562.USD","MANE","LU2322448791.USD","LU0871640123.AUD","LU2430703251.USD","LU0276348264.USD","LU1069347547.HKD","LU1988902786.USD","LU1868837136.USD","LU0894486033.HKD","LU0106261372.USD","LU1712237335.SGD","LU1548497426.USD","LU1084165304.USD","LU1645745479.HKD","LU1852331112.SGD","LU0957791311.USD","LU0889566641.SGD","LU0265550946.USD","LU1196500208.SGD","LU0109394709.USD","LU0225771236.USD","LU2054465674.USD","IE0034235295.USD","MSFX","LU0719512351.SGD","LU1992135399.USD","LU0302445910.USD","LU2213496289.HKD","LU0095938881.EUR","LU1066051811.HKD","LU1035775433.USD","IE0004445239.USD","LU1235294995.USD","LU2764263039.SGD","LU1221951046.USD","BK4161","BK4576","SGXZ81514606.USD","BK4524","IE00B4JS1V06.HKD","LU0820561818.USD","LU1363072403.SGD","LU1732800096.USD","LU1061106388.HKD","LU1804176565.USD","LU2357627491.SGD","LU0345768740.USD","LU2417539215.USD","BK4548","LU0157215616.USD","IE00B775H168.HKD","LU0321505868.SGD","LU2294711713.HKD","LU0494093205.USD","LU2462591350.SGD","LU2211815571.USD","IE00BJLML261.HKD","LU0432979614.USD","BK4209","LU0943347566.SGD","LU2298321311.HKD","IE00B1XK9C88.USD","LU2264538146.SGD","LU0965509283.SGD","LU1366333091.USD","LU2602419157.SGD","LU1861559042.SGD","LU2357125470.USD","LU0823421416.USD","LU2168563687.JPY","LU1670710661.SGD","LU1066051225.USD","LU1551013342.USD","LU1496350502.SGD","BK4550","LU2552382132.HKD","LU1623119135.USD","LU0316494557.USD","LU1989772923.USD","BK4534","LU0106831901.USD","BK4097","BK4599","LU0256863902.USD","IE00BYXW3230.USD","LU0690374961.EUR","LU1868837300.USD","LU2237443465.HKD","LU2403377893.USD","LU2461242641.AUD","QCMU","LU1803068979.SGD","LU1232071149.USD","LU1169589451.USD","LU1861219969.SGD","LU0267386448.USD","SGXZ23171101.USD","LU1228905540.USD","LU1697837992.HKD","LU1721428933.USD","LU2108987350.USD","MRVU","IE00B7SZLL34.SGD","LU0234572021.USD","LU0323240290.USD","LU0912757837.SGD","LU0345769128.USD","BK4535","LU0211326839.USD","LU0342679015.USD","LU1934455194.USD","BK4512","CRMU","LU1917777945.USD","LU2746668461.USD","LU2750360641.GBP","LU2931357623.SGD","LU2237957811.SGD","LU0128525929.USD","GB00B4LPDJ14.GBP","LU0127658192.USD","LU0345774391.USD","BK4147","BK4533","SG9999001424.SGD","LU2125909593.SGD","LU2326559502.SGD","BK0012","LU1720051108.HKD","LU2250418816.HKD","IE00BHPRN162.USD","LU0158827781.USD","LU1032466523.USD","LU1235295455.SGD","LU2083900584.USD","LU1564329461.SGD","LU0109391861.USD","LU0306806265.USD","LU1400636574.HKD","IE00BFSS8Q28.SGD","LU2133065610.SGD","LU0823416689.USD","LU1400636491.USD","LU0345774631.USD","LU2361045086.USD","LU0820562030.AUD","LU0274383776.USD","LU0640476718.USD","LU2023250330.USD","LU2896262040.SGD","LU1642822529.SGD","LU0158827948.USD","LU2381873111.SGD","LU2272731865.HKD","LU1791710582.SGD","LU2087621335.USD","LU0971096721.USD","SG9999014559.SGD","BK4207","IE00BN0W2W23.USD","LU0965509101.SGD","LU2471134879.HKD","LU1868836914.USD","BK4079","LU0963586101.USD","BK4503","LU0054578231.USD","BK4543","LU0314104364.USD","BK4109","LU0048584097.USD","SG9999014914.USD","LU0683600562.USD","BK4213","BK4567","LU2360106947.USD","IE00BDCRKT87.USD","LU0109392836.USD","LU0234570918.USD","LU0786609619.USD","LU1585245621.USD","LU2111349929.HKD","LU2125154935.USD","LU0545039389.USD","LU1059921491.USD","MSFU","LU1861127337.USD","BK4085","LU1145028129.USD","LU2764263203.CNY","LU2077746001.SGD","LU1791710400.SGD","LU2065169927.USD","IE00BZ1G4Q59.USD","SG9999002224.SGD","HK0000914686.HKD","LU2756315318.SGD","LU2430703095.HKD","LU2362540622.SGD","IE000ITXATA3.USD","LU2458330169.SGD","SG9999015952.SGD","IE0001KFT4U8.USD","LU0320765992.SGD","LU1935043023.USD","LU0289739343.SGD","LU0345768153.USD","LU1992135472.HKD","IE00BVYPNQ40.USD","LU2237443895.HKD","BK4108","IE000YTNTUN2.SGD","LU0345770993.USD","LU2286300806.USD","LU0942090050.USD","LU1571399168.USD","BK4204","LLYX","LU0122379950.USD","LU0417517546.SGD","LU2041044095.USD","LU2097344357.USD","LU0354030511.USD","LU1153585028.USD","LU2552382215.SGD","LU0133085943.USD","IE00BGHQDM52.EUR","LU0215105999.USD","LU1043141123.HKD","MSFD","LU2065170008.USD","BK4577","LU0466842654.USD","LU1621768206.USD","LU1496350171.SGD","LU0545562505.USD","LU1894683348.USD","LU2462157665.USD","LU2089283258.USD","LU1261432733.SGD","LU0171293334.USD","IE00BLSP4452.SGD","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630731520","title":"BUZZ-Absci rises as brokerage highlights growing opportunity in hair‑loss market","url":"https://stock-news.laohu8.com/highlight/detail?id=2630731520","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630731520?lang=en_us&edition=fundamental","pubTime":"2026-04-28 00:15","pubTimestamp":1777306525,"startTime":"0","endTime":"0","summary":"BUZZ-Absci rises as brokerage highlights growing opportunity in hairloss market** Shares of AI-based drug developer Absci Corp ABSI.O rise 15.2% to $4.54 in early trading** Brokerage KeyBanc says positive mid-to-late stage data from rival Veradermics MANE.N for its oral hair-loss pill reinforce the view that the hair-loss market is sizable and can support multiple therapies** Estimates a more than $40 bln market opportunity for hair-loss treatments and reiterates a $9 price target on Absci** Shares of peer biotech firm Veradermics jump 37.3% to $93.72, Nektar up ~1% to $92.17** Brokerage says Absci's experimental hair-growth drug ABS-201 could complement rather than compete with existing treatments citing its infrequent dosing of two to three injections over six months** Renewed investor interest in hair-loss therapies follows Nektar Therapeutics' NKTR.O update last week that its experimental injection stimulated hair regrowth in patients with alopecia areata, a patchy hair-loss condit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A1KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4007","BK4121","NKTR","MANE","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630392069","title":"Veradermics Reports Positive Phase 2/3 Data for VDPHL01","url":"https://stock-news.laohu8.com/highlight/detail?id=2630392069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630392069?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:32","pubTimestamp":1777296745,"startTime":"0","endTime":"0","summary":"Veradermics, Incorporated ( ($MANE) ) has provided an announcement. On April 27, 2026, Veradermics reported positive topline results from Part A of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/veradermics-reports-positive-phase-2-3-data-for-vdphl01?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/veradermics-reports-positive-phase-2-3-data-for-vdphl01?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395018","title":"BUZZ-Veradermics jumps after experimental oral hair loss pill posts positive late‑stage trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395018","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395018?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:53","pubTimestamp":1777290827,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics jumps after experimental oral hair loss pill posts positive latestage trial results** Shares of biotech firm Veradermics MANE.N jump 25% to $84.84 premarket** Co says it reported positive latestage trial results for its experimental oral drug for pattern hair loss** Says its pill VDPHL01 targets male pattern hair loss, a common condition in which men gradually lose scalp hair due to genetics and hormones** Says the sixmonth study in more than 500 men showed patients on the drug gained over 30 hairs per square cm versus seven on placebo** Adds that nearly 80% of patients on VDPHL01 reported improvement, compared with about 36% on placebo, with benefits seen as early as two months** Says the pill is a nonhormonal, extendedrelease version of minoxidil and showed no serious heartrelated safety issues** Says it plans further studies, including trials in women, with more results expected in 2026** As of last close, stock flat YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A11O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630539541","title":"Veradermics Shares Gain on Positive Data from Hair Loss Treatment Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2630539541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630539541?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:45","pubTimestamp":1777290300,"startTime":"0","endTime":"0","summary":"Shares of Veradermics climbed after the company shared what it called positive data from a recent trial of its in-development therapy for pattern hair loss.The stock rose 16%, to $79.01, in premarket trading Monday. The stock had its public debut in February, with Veradermics pricing its initial offering of 15.1 million shares at $17 apiece.The biopharmaceutical company said data from a Phase 2/3 clinical trial of the drug, VDPHL01, positions it to become the first Food and Drug Administration-approved oral pill in nearly 30 years for pattern hair loss, as well as a potential best-in-indication treatment option.The recent trial of the treatment met all primary and all key secondary endpoints with statistical significance, demonstrating robust increases in hair count while being generally well tolerated, Veradermics said.Nearly 80% of patients in the once-daily dose arm and 86% of patients in the twice-daily dose arm reported improvement in hair coverage after six months of treatment wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630739824","title":"A new version of an old drug is helping men grow back some of their hair","url":"https://stock-news.laohu8.com/highlight/detail?id=2630739824","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630739824?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:03","pubTimestamp":1777287780,"startTime":"0","endTime":"0","summary":"Veradermics is developing an extended-release version of oral minoxidil. Veradermics is testing an extended-release formulation of oral minoxidil  in clinical trials.A safer - and more effective - formulation of a popular hair-loss treatment led to robust hair growth in a later-stage clinical trial.Veradermics is working on an extended-release version of oral minoxidil that is thought to reduce the heart palpitations and low blood pressure that can occur when people take higher doses of a minoxidil pill. Minoxidil has the same ingredient as Rogaine, which is available topically over the counter. It's also often prescribed off-label as a pill but can't be taken orally in high doses because of those cardiovascular risks.This is where Veradermics comes in. On Monday, the company announced the first batch of late-stage data that showed solid results for its extended-release minoxidil pill. Veradermics' stock  rallied 16.9% in premarket trade.There is another drug called finasteride that wo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630228398","title":"Veradermics Inc - Vdphl01 Shows Favorable Safety Profile With Adverse Event Rates Similar to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2630228398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630228398?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA2PRKW0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630215398","title":"Veradermics Inc - Vdphl01 Meets All Primary and Key Secondary Endpoints With High Statistical Significance","url":"https://stock-news.laohu8.com/highlight/detail?id=2630215398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630215398?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA2PRKW0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630039895","title":"Veradermics’ Oral Vdphl01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2630039895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630039895?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA2PRKW0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630336733","title":"Veradermics to report Phase 2/3 VDPHL01 trial topline results in male hair loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2630336733","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630336733?lang=en_us&edition=fundamental","pubTime":"2026-04-27 04:00","pubTimestamp":1777233624,"startTime":"0","endTime":"0","summary":"Veradermics scheduled investor call and webcast for April 27, 2026, to present topline results from Part A of Phase 2/3 ‘302’ trial of VDPHL01 in males with mild-to-moderate pattern hair loss.Update will cover initial readout from randomized, double-blind, placebo-controlled study of extended-release oral minoxidil tablet.Presentation timing signals near-term catalyst for program positioning ahead of potential late-stage development and commercialization planning.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to generate this news brief via Business Wire  on April 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nNDL9Rnkw7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630833673","title":"Veradermics to Hold Conference Call to Discuss Topline Results From Phase 2/3 ‘302’ Study of Vdphl01 in Males With Mild-to-Moderate Pattern Hair Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2630833673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630833673?lang=en_us&edition=fundamental","pubTime":"2026-04-27 04:00","pubTimestamp":1777233601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nTUA6HXHK8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629331040","title":"Veradermics Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2629331040","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629331040?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:19","pubTimestamp":1776867540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MANE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2026 10:19 ET (14:19 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":114,"code":"91000000","status":"200"}]}}